Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading

Objective— Endoglin, a transforming growth factor-&bgr; superfamily coreceptor, is predominantly expressed in endothelial cells and has essential roles in vascular development. However, whether endoglin is also expressed in vascular smooth muscle cells (VSMCs), especially in vivo, remains controversial. Furthermore, the roles of endoglin in VSMC biology remain largely unknown. Our objective was to examine the expression and determine the function of endoglin in VSMCs during angiogenesis. Approach and Results— Here, we determine that endoglin is robustly expressed in VSMCs. Using CRISPR/CAS9 knockout and short hairpin RNA knockdown in the VSMC/endothelial coculture model system, we determine that endoglin in VSMCs, but not in endothelial cells, promotes VSMCs recruitment by the endothelial cells both in vitro and in vivo. Using an unbiased bioinformatics analysis of RNA sequencing data and further study, we determine that, mechanistically, endoglin mediates VSMC recruitment by promoting VSMC migration and spreading on endothelial cells via increasing integrin/FAK pathway signaling, whereas endoglin has minimal effects on VSMC adhesion to endothelial cells. In addition, we further determine that loss of endoglin in VSMCs inhibits VSMC recruitment in vivo. Conclusions— These studies demonstrate that endoglin has an important role in VSMC recruitment and blood vessel maturation during angiogenesis and also provide novel insights into how discordant endoglin function in endothelial and VSMCs may regulate vascular maturation and angiogenesis.

[1]  E. Boscolo,et al.  Endoglin regulates mural cell adhesion in the circulatory system , 2015, Cellular and Molecular Life Sciences.

[2]  K. Walter,et al.  Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer , 2015, British Journal of Cancer.

[3]  M. Goumans,et al.  Activin Receptor-like Kinase 1 Ligand Trap Reduces Microvascular Density and Improves Chemotherapy Efficiency to Various Solid Tumors , 2015, Clinical Cancer Research.

[4]  W. Young,et al.  Novel Brain Arteriovenous Malformation Mouse Models for Type 1 Hereditary Hemorrhagic Telangiectasia , 2014, PloS one.

[5]  R. Kerbel,et al.  Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment , 2013, Angiogenesis.

[6]  C. Cabañas,et al.  Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration. , 2013, Blood.

[7]  L. Liaw,et al.  BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. , 2012, Blood.

[8]  N. Katsanis,et al.  Endoglin mediates fibronectin/α5β1 integrin and TGF‐β pathway crosstalk in endothelial cells , 2012, The EMBO journal.

[9]  T. Seki,et al.  Age-Dependent Lethality in Novel Transgenic Mouse Models of Central Nervous System Arteriovenous Malformations , 2012, Stroke.

[10]  R. Pyeritz,et al.  Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis , 2011, Genetics in Medicine.

[11]  E Wiercinska,et al.  Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma , 2011, Oncogene.

[12]  J. Santibañez,et al.  The Role of the TGF-β Coreceptor Endoglin in Cancer , 2010, TheScientificWorldJournal.

[13]  Rachael J. Oakenfull,et al.  Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin , 2010, Circulation research.

[14]  T. Nishida,et al.  Role of formation of an ERK-FAK-paxillin complex in migration of human corneal epithelial cells during wound closure in vitro. , 2009, Investigative Ophthalmology and Visual Science.

[15]  J. López-Novoa,et al.  The emerging role of TGF-beta superfamily coreceptors in cancer. , 2009, Biochimica et biophysica acta.

[16]  A. Terzić,et al.  Endoglin plays distinct roles in vascular smooth muscle cell recruitment and regulation of arteriovenous identity during angiogenesis , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[17]  Andrés J. García,et al.  Focal adhesion kinase modulates cell adhesion strengthening via integrin activation. , 2009, Molecular biology of the cell.

[18]  Sophie Astrof,et al.  Fibronectins in vascular morphogenesis , 2009, Angiogenesis.

[19]  A. Magis,et al.  A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. , 2008, Journal of medicinal chemistry.

[20]  G. Blobe,et al.  Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC* , 2008, Journal of Biological Chemistry.

[21]  L. David,et al.  Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.

[22]  S. Landolfo,et al.  Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. , 2008, Gynecologic oncology.

[23]  D. Hammer,et al.  Integrin-mediated signalling through the MAP-kinase pathway. , 2008, IET systems biology.

[24]  A. Fertala,et al.  Type I collagen and collagen mimetics as angiogenesis promoting superpolymers. , 2007, Current pharmaceutical design.

[25]  B. Conley,et al.  Endoglin is required for myogenic differentiation potential of neural crest stem cells. , 2007, Developmental biology.

[26]  G. Blobe,et al.  The Interaction of Endoglin with β-Arrestin2 Regulates Transforming Growth Factor-β-mediated ERK Activation and Migration in Endothelial Cells* , 2007, Journal of Biological Chemistry.

[27]  M. V. Dinther,et al.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.

[28]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[29]  G. Blobe,et al.  The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. , 2007, The Journal of biological chemistry.

[30]  L. David,et al.  Identification of BMP 9 and BMP 10 as functional activators of the orphan activin receptor-like kinase 1 ( ALK 1 ) in endothelial cells , 2007 .

[31]  N. M. Khazenzon,et al.  Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. , 2006, Frontiers in bioscience : a journal and virtual library.

[32]  J. Wrana,et al.  Endoglin Null Endothelial Cells Proliferate Faster and Are More Responsive to Transforming Growth Factor β1 with Higher Affinity Receptors and an Activated Alk1 Pathway* , 2005, Journal of Biological Chemistry.

[33]  E. Morrisey,et al.  High‐efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22α‐Cre transgenic mice , 2005, Genesis.

[34]  M. Goumans,et al.  Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.

[35]  D. Banville,et al.  Endoglin Regulates Cytoskeletal Organization through Binding to ZRP-1, a Member of the Lim Family of Proteins* , 2004, Journal of Biological Chemistry.

[36]  Joshua D. Smith,et al.  Endoglin Controls Cell Migration and Composition of Focal Adhesions , 2004, Journal of Biological Chemistry.

[37]  M. Maio,et al.  Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels , 2003, Oncogene.

[38]  D. Parums,et al.  Inducible expression of human endoglin during inflammation and wound healing in vivo , 2002, Inflammation Research.

[39]  T. Sanchez-Elsner,et al.  Extracellular and Cytoplasmic Domains of Endoglin Interact with the Transforming Growth Factor-β Receptors I and II* , 2002, The Journal of Biological Chemistry.

[40]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[41]  Xin-Yuan Fu,et al.  Focal Adhesion Kinase Activates Stat1 in Integrin-mediated Cell Migration and Adhesion* , 2001, The Journal of Biological Chemistry.

[42]  P. Carmeliet,et al.  Molecular mechanisms of blood vessel growth. , 2001, Cardiovascular research.

[43]  B. Conley,et al.  Endoglin, a TGF-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques. , 2000, Atherosclerosis.

[44]  M. Labinaz,et al.  Endoglin Is Overexpressed After Arterial Injury and Is Required for Transforming Growth Factor-&bgr;–Induced Inhibition of Smooth Muscle Cell Migration , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[45]  Dean Y. Li,et al.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.

[46]  M. Basson,et al.  Human caco-2 motility redistributes FAK and paxillin and activates p38 MAPK in a matrix-dependent manner. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[47]  C. Damsky,et al.  FAK integrates growth-factor and integrin signals to promote cell migration , 2000, Nature Cell Biology.

[48]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[49]  D. Dumont,et al.  A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.

[50]  T. Rando,et al.  Integrin-mediated Muscle Cell Spreading , 1999, The Journal of Biological Chemistry.

[51]  D. Schlaepfer,et al.  Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. , 1999, Journal of cell science.

[52]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[53]  J. Wrana,et al.  Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily* , 1999, The Journal of Biological Chemistry.

[54]  L. Attisano,et al.  Role of Endoglin in Cellular Responses to Transforming Growth Factor-β , 1998, The Journal of Biological Chemistry.

[55]  P. Adam,et al.  Expression of endoglin mRNA and protein in human vascular smooth muscle cells. , 1998, Biochemical and biophysical research communications.

[56]  D. W. Johnson,et al.  Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.

[57]  P. Lastres,et al.  Endoglin modulates cellular responses to TGF-beta 1 , 1996, The Journal of cell biology.

[58]  J. Parsons,et al.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src , 1994, Molecular and cellular biology.

[59]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.

[60]  J. Massagué,et al.  Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. , 1992, The Journal of biological chemistry.

[61]  B. Jacobson,et al.  Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. , 1990, The Journal of investigative dermatology.